<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02784145</url>
  </required_header>
  <id_info>
    <org_study_id>RESISTA-PD</org_study_id>
    <nct_id>NCT02784145</nct_id>
  </id_info>
  <brief_title>Effects of Resistant Starch on Bowel Habits, Fecal Short Chain Fatty Acids and Gut Microbiota in Parkinson Disease</brief_title>
  <acronym>RESISTA-PD</acronym>
  <official_title>Effects of Resistant Starch on Bowel Habits, Fecal Short Chain Fatty Acids and Gut Microbiota in Parkinson Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saarland University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saarland University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will investigate the effects of an 8-week resistant starch (RS)
      supplementation (5 g twice a day) in patients with Parkinson Disease and matched controls on:

        1. symptoms of constipation (assessed by clinical scores);

        2. fecal short chain fatty acid concentrations (measured by chromatography);

        3. gut microbiota composition.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">May 2018</completion_date>
  <primary_completion_date type="Actual">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bowel habits</measure>
    <time_frame>8 weeks</time_frame>
    <description>Number of patients with improved bowel habits</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal short chain fatty acid (SCFA) concentrations</measure>
    <time_frame>8 weeks</time_frame>
    <description>Number of patients with either a) increased, b.) unaltered or c) decreased concentration of short chain fatty acids in fecal samples at 8 weeks (compared to baseline)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Analysis of fecal microbiota composition</measure>
    <time_frame>8 weeks</time_frame>
    <description>Analysis to detect changes between baseline and 8 weeks of resistant starch supplementation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">95</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>RS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Resistant starch supplementation (5 g twice a day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No RS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>PD patients who do not receive resistant starch, but who receive recommendations concerning healthy Nutrition (based on the guidelines of the German Society for Nutrition)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Resistant starch</intervention_name>
    <arm_group_label>RS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recommendation with regard to nutrition</intervention_name>
    <description>Subjects in this arm will receive General recommendations with regard to nutrition based on the guidlines of the German Society for nutrition</description>
    <arm_group_label>No RS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Main Inclusion Criteria:

          -  Written informed to participate

          -  For patients: diagnosis of Parkinson Disease

        Main Exclusion Criteria:

          -  Use of antibiotics, steroids or probiotic supplements

          -  Chronic or acute disorders of the gastrointestinal tract

          -  History of gastrointestinal surgery (other than appendectomy)

          -  For healthy controls: Family history of neurodegenerative disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcus M Unger, PD Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saarladnd University, Department of Neurology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Saarland University</name>
      <address>
        <city>Homburg / Saar</city>
        <state>Saarland</state>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2016</study_first_submitted>
  <study_first_submitted_qc>May 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2016</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saarland University</investigator_affiliation>
    <investigator_full_name>Dr. Marcus Unger</investigator_full_name>
    <investigator_title>PD Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

